• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The serum lipoprotein transport system in health, metabolic disorders, atherosclerosis and coronary heart disease.

作者信息

Gofman John W, Delalla Oliver, Glazier Frank, Freeman Norman K, Lindgren Frank T, Nichols Alex V, Strisower Beverly, Tamplin Arthur R

机构信息

Donner Laboratory of Medical Physics, Division of Medical Physics, Department of Physics and the Radiation Laboratory, University of California, Berkeley, California USA.

出版信息

J Clin Lipidol. 2007 May;1(2):104-41. doi: 10.1016/j.jacl.2007.03.001.

DOI:10.1016/j.jacl.2007.03.001
PMID:21291675
Abstract
摘要

相似文献

1
The serum lipoprotein transport system in health, metabolic disorders, atherosclerosis and coronary heart disease.健康、代谢紊乱、动脉粥样硬化和冠心病中的血清脂蛋白转运系统。
J Clin Lipidol. 2007 May;1(2):104-41. doi: 10.1016/j.jacl.2007.03.001.
2
Correlates and consequences of diffuse atherosclerosis in men with coronary heart disease. Veterans Affairs High-Density Lipoprotein Intervention Trial Study Group.冠心病男性患者弥漫性动脉粥样硬化的相关因素及后果。退伍军人事务部高密度脂蛋白干预试验研究组。
Arch Intern Med. 1996 Jun 10;156(11):1181-8.
3
Lipoprotein analysis. Early methods in the diagnosis of atherosclerosis.
Arch Pathol Lab Med. 1989 Oct;113(10):1101-10.
4
Assessing low levels of high-density lipoprotein cholesterol as a risk factor in coronary heart disease: a working group report and update.评估高密度脂蛋白胆固醇水平低作为冠心病的一个危险因素：一份工作组报告及更新内容
J Am Coll Cardiol. 2004 Mar 3;43(5):717-24. doi: 10.1016/j.jacc.2003.08.061.
5
Serum sex hormones in premenopausal women with coronary heart disease.绝经前冠心病女性的血清性激素
Neuro Endocrinol Lett. 2006 Dec;27(6):758-62.
6
Oral contraceptives and coronary heart disease.口服避孕药与冠心病
J Reprod Med. 1991 Mar;36(3 Suppl):219-25.
7
[Progress in the study of lipoprotein metabolism and atherosclerosis: organ-specific characteristics of lipoprotein metabolic disorders--with special reference to the heart and brain].
Nihon Rinsho. 1988 Mar;46(3):671-8.
8
Therapeutic elevation of HDL-cholesterol to prevent atherosclerosis and coronary heart disease.通过治疗性提高高密度脂蛋白胆固醇来预防动脉粥样硬化和冠心病。
Pharmacol Ther. 2006 Sep;111(3):893-908. doi: 10.1016/j.pharmthera.2006.02.003. Epub 2006 Mar 29.
9
Lipoprotein Lp(a) excess and coronary heart disease.脂蛋白Lp(a)过量与冠心病
Arch Intern Med. 1997 Jun 9;157(11):1170-6.
10
Atherosclerotic risk factors in cardiovascular disease.心血管疾病中的动脉粥样硬化危险因素。
J Reprod Med. 1986 Sep;31(9 Suppl):906-12.

引用本文的文献

1
sJAM-C as a Potential Biomarker for Coronary Artery Stenosis: Insights from a Clinical Study in Coronary Heart Disease Patients.可溶性连接黏附分子C作为冠状动脉狭窄的潜在生物标志物：来自冠心病患者临床研究的见解
Diabetes Metab Syndr Obes. 2024 Dec 21;17:4857-4865. doi: 10.2147/DMSO.S478526. eCollection 2024.
2
Predictors of plasma HDL-C concentrations in the Coronary Artery Risk Development in Young Adults (CARDIA) study.青年动脉粥样硬化风险发展研究（CARDIA研究）中血浆高密度脂蛋白胆固醇（HDL-C）浓度的预测因素
J Lipid Res. 2025 Jan;66(1):100717. doi: 10.1016/j.jlr.2024.100717. Epub 2024 Dec 2.
3
Coronary artery calcification burden, atherogenic index of plasma, and risk of adverse cardiovascular events in the general population: evidence from a mediation analysis.
冠状动脉钙化负担、血浆致动脉粥样硬化指数与一般人群不良心血管事件风险：中介分析的证据。
Lipids Health Dis. 2024 Aug 20;23(1):258. doi: 10.1186/s12944-024-02255-1.
4
Proteomic Analysis of Human Chylomicron Remnants Isolated by Apolipoprotein B-48 Immunoprecipitation.通过载脂蛋白B-48免疫沉淀法分离的人乳糜微粒残余物的蛋白质组学分析
J Atheroscler Thromb. 2025 Feb 1;32(2):226-238. doi: 10.5551/jat.64920. Epub 2024 Jul 31.
5
From Atheroma to Atherogenic Index, Secular Evidence.从动脉粥样硬化到动脉粥样硬化指数，长期证据。
Arq Bras Cardiol. 2024 Mar 4;120(12):e20230819. doi: 10.36660/abc.20230819. eCollection 2024.
6
Potential Benefits and Risks Associated with the Use of Statins.使用他汀类药物相关的潜在益处和风险。
Pharmaceutics. 2024 Feb 1;16(2):214. doi: 10.3390/pharmaceutics16020214.
7
How the JCI's most-cited paper sparked the field of lipoprotein research.《细胞》杂志最具引用率的论文如何引发脂蛋白研究领域的发展。
J Clin Invest. 2024 Feb 15;134(4):e177475. doi: 10.1172/JCI177475.
8
A Century of Milestones and Breakthroughs Related to Low- and High-Density Lipoproteins.与低密度和高密度脂蛋白相关的百年里程碑与突破
Arterioscler Thromb Vasc Biol. 2024 Jan;44(1):7-11. doi: 10.1161/ATVBAHA.123.319482. Epub 2023 Dec 27.
9
Understanding the molecular mechanisms of statin pleiotropic effects.了解他汀类药物多效性作用的分子机制。
Arch Toxicol. 2023 Jun;97(6):1529-1545. doi: 10.1007/s00204-023-03492-6. Epub 2023 Apr 21.
10
Revisiting cardiovascular risk reduction in type 2 diabetes and dyslipidemia.重新审视2型糖尿病和血脂异常患者的心血管风险降低问题。
Int J Cardiol Cardiovasc Risk Prev. 2022 Jun 23;14:200141. doi: 10.1016/j.ijcrp.2022.200141. eCollection 2022 Sep.